Trials / Conditions / Myopic Choroidal Neovascularization
Myopic Choroidal Neovascularization
5 registered clinical trials studyying Myopic Choroidal Neovascularization — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Deep Learning-Based OCTA Quantification and Modeling for Predicting Long-Term Anti-VEGF Efficacy in mCNV NCT07402629 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Completed | A Study to Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New NCT04524910 | Bayer | — |
| Completed | VEGF and PEDF in Patients With Myopic Choroidal Neovascularization NCT02175940 | Università degli Studi di Brescia | — |
| Unknown | Ranibizumab for Myopic Neovascularization NCT01246089 | Instituto de Olhos de Goiania | Phase 4 |
| Completed | Bevacizumab Intravitreal for Myopic Choroidal Neovascularization NCT00797992 | Instituto de Olhos de Goiania | Phase 4 |